Postpartum depression is common among new mothers, according to current statistics. Understanding its risks and symptoms can help women receive the right treatment.

Having a baby is a life-changing event and brings about a new set of challenges. Even in a best-case scenario, giving birth is an emotional, stressful endeavor. Many women experience the baby blues, or intense mood swings that happen during the first few days to few weeks after birth. However, some will go on to develop postpartum depression, with more intense, longer-lasting feelings of sadness, anxiety or hopelessness.

Some stigma still surrounds postpartum depression. Many people are not aware of what it is and how serious it can be. An overview of facts about postpartum depression can help people learn about its signs, risk factors and widespread prevalence.

Prevalence of Postpartum Depression

About 1 in 7 new mothers end up developing postpartum depression. As many as half of all women who have postpartum depression are not diagnosed or do not seek treatment for it. Fortunately, the prevalence of postpartum depression in the United States has decreased slightly over the past few decades.

Women aren’t the only ones affected by this condition. An estimated 10.4% of new fathers experience symptoms of depression, more than twice the rate of other men.

Postpartum Depression vs. Baby Blues

Shortly after giving birth, women experience a sharp drop in the levels of the pregnancy hormones progesterone and estrogen. Around half of all new mothers experience mood swings related to these hormonal changes. Known as the “baby blues,” these mood swings often involve a broad spectrum of emotion, ranging from feelings of sadness and tearfulness to pleasure and joy. Typically, baby blues subside within the first few weeks after delivery.

But postpartum depression is different from the baby blues. The symptoms of postpartum depression last longer and significantly impact a woman’s ability to return to a normal life after giving birth.

Postpartum Depression Risk Factors

Any woman who has recently given birth is susceptible to developing postpartum depression. Certain psychological, obstetric, social and lifestyle risk factors can make a woman more likely to develop the condition.

Psychological Factors:

  • History of depression or anxiety
  • History of premenstrual syndrome (PMS)
  • A negative attitude toward the baby
  • Disappointment with the baby’s gender
  • History of sexual abuse

Obstetric Factors:

  • High-risk pregnancy
  • Emergency cesarean section (C-section)
  • Hospitalization during pregnancy
  • Umbilical cord prolapse
  • Premature birth
  • Low birth weight
  • Low hemoglobin

Social Factors:

Lifestyle Factors:

  • Smoking during pregnancy
  • Not getting enough sleep
  • Low physical activity or exercise
  • Poor diet

Rates of Postpartum Depression and Co-Occurring Disorders

Several related conditions frequently co-occur with postpartum depression. They often have several symptoms in common.

  • Postpartum Psychosis: Cases of postpartum psychosis can occur along with postpartum depression. The rate of psychosis is relatively low, only affecting up to 3% of new mothers. However, diagnosing psychosis is especially important because it can significantly raise the risk of self-harm or infanticide.
  • Bipolar Disorder: Between 21–54% of women with postpartum depression also have bipolar disorder. The two conditions often occur together along with psychotic symptoms.
  • Anxiety: Anxiety is a common symptom of postpartum depression. Along with postpartum depression, mothers frequently also experience symptoms of anxiety disorders, affecting nearly two-thirds of all women with postpartum depression.
  • Obsessive-Compulsive Disorder: New mothers have a much higher risk than other women for developing obsessive-compulsive disorder (OCD). Women who already have OCD are at risk for their symptoms getting worse after they give birth, especially if they also have postpartum depression.

Rates of Suicide or Infanticide

Intrusive, unwanted thoughts of self-harm or harming their infants are surprisingly common among new mothers. Half of all new mothers report having thoughts like these. Thankfully, these thoughts are not usually linked to an actual risk of causing harm.

Because they are rare, the suicide rate and incidence of infanticide are hard to estimate in cases of postpartum depression. Around 3% of new mothers with depression report having suicidal thoughts, though they don’t always act on them. Infanticide is often caused by postpartum psychosis.

Feelings of depression or anxiety can lead to suicidal thinking. If you or a loved one is experiencing suicidal thoughts or tendencies, call the National Suicide Prevention Hotline at 1-800-273-8255.

Statistics on Postpartum Depression Treatment

Only half of all new mothers diagnosed with postpartum depression receive treatment for it. When left untreated, postpartum depression can become debilitating, significantly interfering with daily life. Mothers who receive effective treatment during their first month after giving birth have a much better prognosis than if they go untreated.

Treatment for postpartum depression often includes antidepressant medication and counseling or cognitive behavioral therapy. The FDA recently approved a new drug for the treatment of postpartum depression. Called Brexanolone (brand name Zulresso), this is the first medication approved specifically for postpartum depression. The medication works by giving women a low dose of progesterone and estrogen to help make up for the sudden drop in these hormones following childbirth.

If you are experiencing thoughts of suicide or harming yourself or others, seek help immediately. Free, confidential help is available 24-7 at the National Suicide Prevention Lifeline at 1-800-273-8255.

If you are affected by postpartum depression and a substance use disorder, consider contacting The Recovery Village. Representatives are available to answer your questions and recommend comprehensive treatment options.

a woman is standing with her arms crossed.
Editor – Megan Hull
Megan Hull is a content specialist who edits, writes and ideates content to help people find recovery. Read more
a woman with glasses is smiling for the camera.
Medically Reviewed By – Dr. Anna Pickering, PhD
Dr. Anna Pickering has a PhD in Cell and Molecular Biology. Anna works as a medical writer. She grew up in Oregon, where she developed a love for science, nature, and writing. Read more

Mughal S, Siddiqui W. “Postpartum Depression.” National Center for Biotechnology Information, February 23, 2019. Accessed April 20, 2019.

Ko JY, Rockhill KM, Tong VT, Morrow B, Farr SL. “Trends in Postpartum Depressive Symptoms[…]2004, 2008, and 2012.” Morbidity and Mortality Weekly Report, Centers for Disease Control and Prevention, February 17, 2017. Accessed April 20, 2019.

Kumar SV, Oliffe JL, Kelly MT. “Promoting Postpartum Mental Health in Fathers: Recommendations for Nurse Practitioners.” American Journal of Men’s Health, November 28, 2017. Accessed April 20, 2019.

Wilkinson A, Anderson S, Wheeler SB. “Screening for and Treating Postpartum De[…]fectiveness Analysis.” Maternal and Child Health Journal, April 2017. Accessed April 20, 2019.

Sharma V, Doobay M, Baczynski C. “Bipolar postpartum depression: An update and recommendations.” Journal of Affective Disorders, September 2017. Accessed April 20, 2019.

Wisner KL. Sit DKY, McShea MC. “Onset Timing, Thought of Self-harm, and […] Depression Findings.” JAMA Psychiatry, 2013. Accessed April 20, 2019.

Collardeau F, Corbyn B, Abramowitz J, Janssen PA, Woody S, Fairbrother N. “Maternal unwanted and intrusive thoughts[…]riod: study protocol.” BMC Psychiatry, March 21, 2019. Accessed April 20, 2019.

Mikšić Š, Miškulin M, Juranić B, Rakošec Ž, Včev A, Degmečić D. “Depression and Suicidality during Pregnancy.” Psychiatria Danubina, 2018. Accessed April 20, 2019.

Barnes DL, Brown J. “Understanding Postpartum Psychosis and Infanticide.” Concordia University Saint Paul, April 29, 2016. Accessed April 20, 2019.

Dyer O. “Postpartum depression: new drug will be […]ed at approved sites.” British Medical Journal, March 26, 2019. Accessed April 20, 2019.

Medical Disclaimer

The Recovery Village aims to improve the quality of life for people struggling with substance use or mental health disorder with fact-based content about the nature of behavioral health conditions, treatment options and their related outcomes. We publish material that is researched, cited, edited and reviewed by licensed medical professionals. The information we provide is not intended to be a substitute for professional medical advice, diagnosis or treatment. It should not be used in place of the advice of your physician or other qualified healthcare providers.